This inventor holds 1 USPTO granted patent. Top assignee: Medtronic Minimed, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Jing Liu in Continuous Glucose Monitoring
Introduction
Jing Liu is an accomplished inventor based in Woodland Hills, CA (US). He has made significant contributions to the field of medical technology, particularly in the area of continuous glucose monitoring systems. His innovative work aims to enhance the accuracy and usability of glucose monitoring for individuals with diabetes.
Latest Patents
Jing Liu holds a patent for "Methods, systems, and devices for continuous glucose monitoring." This patent describes a continuous glucose monitoring system that utilizes electrode current (Isig) signals, Electrochemical Impedance Spectroscopy (EIS), and Vcntr values. The goal of this innovation is to optimize sensor glucose (SG) calculation, thereby reducing the need for blood glucose (BG) calibration requests from users. This advancement is crucial for improving the user experience and reliability of glucose monitoring devices.
Career Highlights
Jing Liu is currently employed at Medtronic Minimed, Inc., a leading company in diabetes management technology. His work at Medtronic has allowed him to focus on developing cutting-edge solutions that address the challenges faced by individuals managing diabetes. With a patent portfolio that includes 1 patent, Liu's contributions are recognized within the industry.
Collaborations
Jing Liu collaborates with talented professionals in his field, including Georgios Mallas and Andrea Varsavsky. Their combined expertise fosters an environment of innovation and creativity, leading to advancements in medical technology.
Conclusion
Jing Liu's work in continuous glucose monitoring exemplifies the impact of innovation in healthcare. His patent and contributions at Medtronic Minimed, Inc. highlight the importance of developing technologies that improve the quality of life for individuals with diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
